These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 34284042)

  • 1. Sustained treatment with an α5 GABA A receptor negative allosteric modulator delays excitatory circuit development while maintaining GABAergic neurotransmission.
    Nuwer JL; Brady ML; Povysheva NV; Coyne A; Jacob TC
    Neuropharmacology; 2021 Oct; 197():108724. PubMed ID: 34284042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term α5 GABA A receptor negative allosteric modulator treatment reduces NMDAR-mediated neuronal excitation and maintains basal neuronal inhibition.
    Nuwer JL; Povysheva N; Jacob TC
    Neuropharmacology; 2023 Oct; 237():109587. PubMed ID: 37270156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depolarizing, inhibitory GABA type A receptor activity regulates GABAergic synapse plasticity via ERK and BDNF signaling.
    Brady ML; Pilli J; Lorenz-Guertin JM; Das S; Moon CE; Graff N; Jacob TC
    Neuropharmacology; 2018 Jan; 128():324-339. PubMed ID: 29074304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective inhibition of extra-synaptic α5-GABA
    Etherington LA; Mihalik B; Pálvölgyi A; Ling I; Pallagi K; Kertész S; Varga P; Gunn BG; Brown AR; Livesey MR; Monteiro O; Belelli D; Barkóczy J; Spedding M; Gacsályi I; Antoni FA; Lambert JJ
    Neuropharmacology; 2017 Oct; 125():353-364. PubMed ID: 28807671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haploinsufficiency of GABA
    Ge Y; Craig AM
    J Neurosci; 2024 Aug; 44(32):. PubMed ID: 38942471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of a tonic inhibitory conductance in mouse hippocampal neurones by negative allosteric modulators of α5 subunit-containing γ-aminobutyric acid type A receptors: implications for treating cognitive deficits.
    Manzo MA; Wang DS; Li WW; Pinguelo A; Popa MO; Khodaei S; Atack JR; Ross RA; Orser BA
    Br J Anaesth; 2021 Mar; 126(3):674-683. PubMed ID: 33388140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Input-Specific Synaptic Location and Function of the α5 GABA
    Magnin E; Francavilla R; Amalyan S; Gervais E; David LS; Luo X; Topolnik L
    J Neurosci; 2019 Jan; 39(5):788-801. PubMed ID: 30523065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct regulation of tonic GABAergic inhibition by NMDA receptor subtypes.
    Wu K; Castellano D; Tian Q; Lu W
    Cell Rep; 2021 Nov; 37(6):109960. PubMed ID: 34758303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the Selective α5-GABAAR Antagonist S44819 on Excitability in the Human Brain: A TMS-EMG and TMS-EEG Phase I Study.
    Darmani G; Zipser CM; Böhmer GM; Deschet K; Müller-Dahlhaus F; Belardinelli P; Schwab M; Ziemann U
    J Neurosci; 2016 Dec; 36(49):12312-12320. PubMed ID: 27927951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurobiology and Therapeutic Potential of α5-GABA Type A Receptors.
    Jacob TC
    Front Mol Neurosci; 2019; 12():179. PubMed ID: 31396049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NMDA receptor activation enhances inhibitory GABAergic transmission onto hippocampal pyramidal neurons via presynaptic and postsynaptic mechanisms.
    Xue JG; Masuoka T; Gong XD; Chen KS; Yanagawa Y; Law SK; Konishi S
    J Neurophysiol; 2011 Jun; 105(6):2897-906. PubMed ID: 21471392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2-Guanidine-4-methylquinazoline acts as a novel competitive antagonist of A type γ-aminobutyric acid receptors.
    Xiao X; Zhu MX; Xu TL
    Neuropharmacology; 2013 Dec; 75():126-37. PubMed ID: 23916476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced Dendritic Inhibition and Impaired NMDAR Activation in a Mouse Model of Down Syndrome.
    Schulz JM; Knoflach F; Hernandez MC; Bischofberger J
    J Neurosci; 2019 Jun; 39(26):5210-5221. PubMed ID: 31000585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synaptic localization of α5 GABA (A) receptors via gephyrin interaction regulates dendritic outgrowth and spine maturation.
    Brady ML; Jacob TC
    Dev Neurobiol; 2015 Nov; 75(11):1241-51. PubMed ID: 25663431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of Inhibitory Synaptic Plasticity Enhances Tonic Current by Increasing the Content of α5-Subunit Containing GABA
    Wyroślak M; Lebida K; Mozrzymas JW
    Neuroscience; 2021 Jul; 467():39-46. PubMed ID: 34033868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of dendritic tonic GABAergic inhibition regulates excitability and plasticity in CA1 pyramidal neurons.
    Groen MR; Paulsen O; Pérez-Garci E; Nevian T; Wortel J; Dekker MP; Mansvelder HD; van Ooyen A; Meredith RM
    J Neurophysiol; 2014 Jul; 112(2):287-99. PubMed ID: 24760781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid Antidepressant Action and Restoration of Excitatory Synaptic Strength After Chronic Stress by Negative Modulators of Alpha5-Containing GABAA Receptors.
    Fischell J; Van Dyke AM; Kvarta MD; LeGates TA; Thompson SM
    Neuropsychopharmacology; 2015 Oct; 40(11):2499-509. PubMed ID: 25900119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dendrite-targeting interneurons control synaptic NMDA-receptor activation via nonlinear α5-GABA
    Schulz JM; Knoflach F; Hernandez MC; Bischofberger J
    Nat Commun; 2018 Sep; 9(1):3576. PubMed ID: 30177704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Negative Allosteric Modulator for α5 Subunit-Containing GABA Receptors Exerts a Rapid and Persistent Antidepressant-Like Action without the Side Effects of the NMDA Receptor Antagonist Ketamine in Mice.
    Zanos P; Nelson ME; Highland JN; Krimmel SR; Georgiou P; Gould TD; Thompson SM
    eNeuro; 2017; 4(1):. PubMed ID: 28275719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quercetin Reduces Cortical GABAergic Transmission and Alleviates MK-801-Induced Hyperactivity.
    Fan HR; Du WF; Zhu T; Wu YJ; Liu YM; Wang Q; Wang Q; Gu X; Shan X; Deng S; Zhu T; Xu TL; Ge WH; Li WG; Li F
    EBioMedicine; 2018 Aug; 34():201-213. PubMed ID: 30057312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.